Comparative genomics of prevaccination and modern Bordetella pertussis strains

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Bart, Marieke J ^a,b   van Gent, Marjolein ^a   van der Heide, Han G J ^a   Boekhorst, Jos ^c   Hermans, Peter ^b   Parkhill, Julian ^d   Mooi, Frits R ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS TOXIN; PERTUSSIS VACCINE; SPACER DNA;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BORDETELLA PERTUSSIS; GENE ACTIVATION; GENE CONTROL; GENE INACTIVATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PHYLOGENY; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE; VACCINATION; ALLELE; BACTERIAL GENE; CODON; COMPARATIVE STUDY; DNA SEQUENCE; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC SELECTION; GENETICS; GENOMICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; OPEN READING FRAME; PATHOGENICITY; REGULATORY SEQUENCE; SPECIES DIFFERENCE; TIME; VIRULENCE;

BORDETELLA PERTUSSIS;

ALLELES; BORDETELLA PERTUSSIS; CODON; DNA, INTERGENIC; GENE DELETION; GENES, BACTERIAL; GENOMICS; MUTAGENESIS, INSERTIONAL; OPEN READING FRAMES; PERTUSSIS VACCINE; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; REGULATORY SEQUENCES, NUCLEIC ACID; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; TIME FACTORS; VACCINATION; VIRULENCE;

EID: 78149302573     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-627     Document Type: Article

References (59)

1. Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol 2010, 10(1):36-49. 10.1016/j.meegid.2009.10.007, 19879977.
2. Diavatopoulos DA, Cummings CA, van der Heide HG, van Gent M, Liew S, Relman DA, Mooi FR. Characterization of a highly conserved island in the otherwise divergent Bordetella holmesii and Bordetella pertussis genomes. J Bacteriol 2006, 188(24):8385-8394. 10.1128/JB.01081-06, 1698220, 17041054.
3. van der Zee A, Groenendijk H, Peeters M, Mooi FR. The differentiation of Bordetella parapertussis and Bordetella bronchiseptica from humans and animals as determined by DNA polymorphism mediated by two different insertion sequence elements suggests their phylogenetic relationship. Int J Syst Bacteriol 1996, 46(3):640-647. 10.1099/00207713-46-3-640, 8782670.
4. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR. Bordetella pertussis, the Causative Agent of Whooping Cough, Evolved from a Distinct, Human-Associated Lineage of B. bronchiseptica. PLoSPathog 2005, 1(4):373-383.
5. van der Zee A, Mooi F, Van Embden J, Musser J. Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J Bacteriol 1997, 179(21):6609-6617. 179586, 9352907.
6. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, Harris DE, Holden MT, Churcher CM, Bentley SD, Mungall KL, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. NatGenet 2003, 35(1):32-40.
7. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis?. Lancet InfectDis 2003, 3(7):413-418.
8. de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rumke HC, Conyn-van Spaendonck MA. Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis 2000, 6(4):348-357. 10.3201/eid0604.000404, 2640897, 10905967.
9. He Q, Mertsola J. Factors contributing to pertussis resurgence. FutureMicrobiol 2008, 3:329-339.
10. Berbers GA, de Greeff SC, Mooi FR. Improving pertussis vaccination. HumVaccin 2009, 5(7):497-503.
11. de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 2006, 53(2):106-113. 10.1016/j.jinf.2005.10.020, 16352342.
12. Cromer BA, Goydos J, Hackell J, Mezzatesta J, Dekker C, Mortimer EA. Unrecognized pertussis infection in adolescents. Am J Dis Child 1993, 147(5):575-577.
13. Hodder SL, Cherry JD, Mortimer EA, Ford AB, Gornbein J, Papp K. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. ClinInfectDis 2000, 31(1):7-14.
14. Ward JI, Cherry JD, Chang SJ, Partridge S, Keitel W, Edwards K, Lee M, Treanor J, Greenberg DP, Barenkamp S, et al. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). ClinInfectDis 2006, 43(2):151-157.
15. Halperin SA. The control of pertussis - 2007 and beyond. NEnglJ Med 2007, 356(2):110-113.
16. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998, 66(2):670-675. 107955, 9453625.
17. Kallonen T, He Q. Bordetella pertussis strain variation and evolution postvaccination. Expert Rev Vaccines 2009, 8(7):863-875. 10.1586/erv.09.46, 19538113.
18. Hozbor D, Mooi F, Flores D, Weltman G, Bottero D, Fossati S, Lara C, Gaillard ME, Pianciola L, Zurita E, et al. Pertussis epidemiology in Argentina: trends over 2004-2007. J Infect 2009, 59(4):225-231. 10.1016/j.jinf.2009.07.014, 19651156.
19. King AJ, Berbers G, van Oirschot HF, Hoogerhout P, Knipping K, Mooi FR. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology 2001, 147(Pt 11):2885-2895.
20. Watanabe M, Nagai M. Effect of acellular pertussis vaccine against various strains of Bordetella pertussis in a murine model of respiratory infection. J Health Science 2002, 48(6):560-564.
21. Gzyl A, Augustynowicz E, Gniadek G, Rabczenko D, Dulny G, Slusarczyk J. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates. Vaccine 2004, 22(17-18):2122-2128. 10.1016/j.vaccine.2003.12.006, 15149768.
22. Fingermann M, Fernandez J, Sisti F, Rodriguez ME, Gatti B, Bottero D, Graieb A, Gaillard ME, Ayala SG, Mooi FR, et al. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production. Vaccine 2006, 24(17):3513-3521. 10.1016/j.vaccine.2006.02.026, 16545509.
23. Mooi FR, van Loo IHM, van Gent M, He Q, Heuvelman CJ, Bart MJ, de Greeff SC, Diavatopoulos DA, Teunis PF, Nagelkerke NJ, et al. Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence. Emerg Infect Dis 2009, 15(8):1206-1213. 10.3201/eid1508.081511, 2815961, 19751581.
24. Carbonetti NH, Artamonova GV, Van Rooijen N, Ayala VI. Pertussis Toxin Targets Airway Macrophages to Promote Bordetella pertussis Infection of the Respiratory Tract. Infect Immun 2007, 75(4):1713-1720. 10.1128/IAI.01578-06, 1865687, 17242062.
25. Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ET. Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. JClinInvest 2005, 115(12):3594-3601.
26. van Loo IH, Mooi FR. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology 2002, 148(Pt 7):2011-2018.
27. Gogol EB, Cummings CA, Burns RC, Relman DA. Phase variation and microevolution at homopolymeric tracts in Bordetella pertussis. BMCGenomics 2007, 8:122.
28. Maharjan RP, Gu C, Reeves PR, Sintchenko V, Gilbert GL, Lan R. Genome-wide analysis of single nucleotide polymorphisms in Bordetella pertussis using comparative genomic sequencing. Res Microbiol 2008, 159(9-10):602-608. 10.1016/j.resmic.2008.08.004, 18790049.
29. Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, Goodhead I, Rance R, Baker S, Maskell DJ, Wain J, et al. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet 2008, 40(8):987-993. 10.1038/ng.195, 2652037, 18660809.
30. Monot M, Honore N, Garnier T, Araoz R, Coppee JY, Lacroix C, Sow S, Spencer JS, Truman RW, Williams DL, et al. On the origin of leprosy. Science 2005, 308(5724):1040-1042. 10.1126/science/1109759, 15894530.
31. Cummings CA, Brinig MM, Lepp PW, van de Pas S, Relman DA. Bordetella species are distinguished by patterns of substantial gene loss and host adaptation. J Bacteriol 2004, 186(5):1484-1492. 10.1128/JB.186.5.1484-1492.2004, 344407, 14973121.
32. Heikkinen E, Kallonen T, Saarinen L, Sara R, King AJ, Mooi FR, Soini JT, Mertsola J, He Q. Comparative Genomics of Bordetella pertussis Reveals Progressive Gene Loss in Finnish Strains. PLoS ONE 2007, 2(9):e904. 10.1371/journal.pone.0000904, 1975675, 17878939.
33. Bouchez V, Caro V, Levillain E, Guigon G, Guiso N. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoSONE 2008, 3(6):e2437.
34. King AJ, van Gorkom T, Pennings JL, van der Heide HG, He Q, Diavatopoulos D, Heuvelman K, van Gent M, van Leeuwen K, Mooi FR. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMCGenomics 2008, 9(1):311.
35. King AJ, van Gorkom T, van der Heide HG, Advani A, van der Lee S. Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift?. BMC Genomics 2010, 11(1):64. 10.1186/1471-2164-11-64, 2834637, 20102608.
36. Caro V, Bouchez V, Guiso N. Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?. J Clin Microbiol 2008, 46(6):2125-2128. 10.1128/JCM.02484-07, 2446832, 18385436.
37. Stibitz S. The bvg regulon. Bordetella Molecular Microbiology 2007, 47-67. Horizon Bioscience, Norfolk, UK.
38. Novichkov PS, Wolf YI, Dubchak I, Koonin EV. Trends in prokaryotic evolution revealed by comparison of closely related bacterial and archaeal genomes. J Bacteriol 2009, 191(1):65-73. 10.1128/JB.01237-08, 2612427, 18978059.
39. Rocha EP, Smith JM, Hurst LD, Holden MT, Cooper JE, Smith NH, Feil EJ. Comparisons of dN/dS are time dependent for closely related bacterial genomes. J TheorBiol 2006, 239(2):226-235.
40. Yang Z, Bielawski JP. Statistical methods for detecting molecular adaptation. Trends Ecol Evol 2000, 15(12):496-503. 10.1016/S0169-5347(00)01994-7, 11114436.
41. van Loo IH, Heuvelman KJ, King AJ, Mooi FR. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. JClinMicrobiol 2002, 40(6):1994-2001.
42. Packard ER, Parton R, Coote JG, Fry NK. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J MedMicrobiol 2004, 53(Pt 5):355-365.
43. Panina EM, Mattoo S, Griffith N, Kozak NA, Yuk MH, Miller JF. A genome-wide screen identifies a Bordetella type III secretion effector and candidate effectors in other species. Mol Microbiol 2005, 58(1):267-279. 10.1111/j.1365-2958.2005.04823.x, 16164564.
44. French CT, Panina EM, Yeh SH, Griffith N, Arambula DG, Miller JF. The Bordetella T3SS effector BteA contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts. Cell Microbiol 2009,
45. Willems R, Paul A, van der Heide HG, ter Avest AR, Mooi FR. Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J 1990, 9(9):2803-2809. 551991, 1975238.
46. van der Woude MW, Baumler AJ. Phase and antigenic variation in bacteria. ClinMicrobiolRev 2004, 17(3):581-611. table.
47. van Gent M, de Greeff SC, van der Heide HG, Mooi FR. An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands. Vaccine 2009, 27(13):1898-1903. 10.1016/j.vaccine.2009.01.111, 19368769.
48. Winfield MD, Groisman EA. Phenotypic differences between Salmonella and Escherichia coli resulting from the disparate regulation of homologous genes. Proc Natl Acad Sci USA 2004, 101(49):17162-17167. 10.1073/pnas.0406038101, 534605, 15569938.
49. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, Chambers HF, Lu Y, Otto M. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2009, 106(14):5883-5888. 10.1073/pnas.0900743106, 2667066, 19293374.
50. Osborne SE, Walthers D, Tomljenovic AM, Mulder DT, Silphaduang U, Duong N, Lowden MJ, Wickham ME, Waller RF, Kenney LJ, et al. Pathogenic adaptation of intracellular bacteria by rewiring a cis-regulatory input function. Proc Natl Acad Sci USA 2009, 106(10):3982-3987. 10.1073/pnas.0811669106, 2645909, 19234126.
51. Perez JC, Groisman EA. Transcription factor function and promoter architecture govern the evolution of bacterial regulons. Proc Natl Acad Sci USA 2009, 106(11):4319-4324. 10.1073/pnas.0810343106, 2649204, 19251636.
52. Huse SM, Huber JA, Morrison HG, Sogin ML, Welch DM. Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol 2007, 8(7):R143. 10.1186/gb-2007-8-7-r143, 2323236, 17659080.
53. Guindon S, Delsuc F, Dufayard JF, Gascuel O. Estimating maximum likelihood phylogenies with PhyML. Methods Mol Biol 2009, 537:113-137. full_text, 19378142.
54. Mooi FR, He Q, van Oirschot H, Mertsola J. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun 1999, 67(6):3133-3134. 96632, 10338531.
55. Mooi FR, Hallander H, Wirsing von Konig CH, Hoet B, Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. EurJ ClinMicrobiolInfectDis 2000, 19(3):174-181.
56. Mastrantonio P, Spigaglia P, van Oirschot H, van der Heide HG, Heuvelman K, Stefanelli P, Mooi FR. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 1999, 145(Pt 8):2069-2075. 10.1099/13500872-145-8-2069, 10463173.
57. Tsang RS, Lau AK, Sill ML, Halperin SA, Van Caeseele P, Jamieson F, Martin IE. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. JClinMicrobiol 2004, 42(11):5364-5367.
58. Herrou J, Debrie AS, Willery E, Renaud-Mongenie G, Locht C, Mooi F, Jacob-Dubuisson F, Antoine R. Molecular evolution of the two-component system BvgAS involved in virulence regulation in Bordetella. PLoS One 2009, 4(9):e6996. 10.1371/journal.pone.0006996, 2737282, 19750014.
59. Brinig MM, Cummings CA, Sanden GN, Stefanelli P, Lawrence A, Relman DA. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation. J Bacteriol 2006, 188(7):2375-2382. 10.1128/JB.188.7.2375-2382.2006, 1428402, 16547023.